This trial is testing a new drug, M1774, to see if it is safe and effective when used alone or with another drug, niraparib.
12 Primary · 84 Secondary · Reporting Duration: Baseline up to 2.2 years
Experimental Treatment
130 Total Participants · 5 Treatment Groups
Primary Treatment: M1774 · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: